Angiosarcoma treated with checkpoint inhibitors: A single-institution experience.

e22543Background: Angiosarcoma (AS) is a rare endothelial malignancy with only 2–3 new cases per one million diagnosed yearly but is among the most aggressive soft tissue sarcomas. Some cutaneous a...